Not applicableUnknownNCT02303353What this trial is testingData Base Project for Acquisition of Cancer Patient Data in Practices and Ambulant TherapyWho this might be right forCarcinoma SPGO Research Mannheim GmbH 2,000
Early research (Phase 1)Looking for participantsNCT05245500What this trial is testingPhase 1 Study of MRTX1719 in Solid Tumors With MTAP DeletionWho this might be right forMesotheliomaNon Small Cell Lung CancerMalignant Peripheral Nerve Sheath Tumors+3 more Bristol-Myers Squibb 336
Early research (Phase 1)Study completedNCT02279433What this trial is testingA First-in-human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of DS-6051bWho this might be right forSolid Tumors Nuvation Bio Inc. 46
Testing effectiveness (Phase 2)Study completedNCT02620865What this trial is testingBATS With in Combination With Low Dose IL-1 and GM-CSF for Advanced Pancreatic CancerWho this might be right forMetastatic Pancreatic AdenocarcinomaRecurrent Pancreatic CarcinomaStage III Pancreatic Cancer+1 more Barbara Ann Karmanos Cancer Institute 2
Not applicableLooking for participantsNCT07273409What this trial is testingPancreatic Neuroendocrine Tumour - Optimal Surgical Debulking or NotWho this might be right forPancreatic Neuroendocrine Tumor Uppsala University 200
Not applicableUnknownNCT04440800What this trial is testingFeasibility of Wearable Activity Trackers for Detection of TOXicity in People Receiving Systemic Anticancer TreatmentWho this might be right forLung Cancer, Small CellPancreatic CancerGastric Cancer+3 more Royal Marsden NHS Foundation Trust 50
Early research (Phase 1)Active Not RecruitingNCT06238479What this trial is testingLY4101174 in Participants With Recurrent, Advanced or Metastatic Solid TumorsWho this might be right forMetastatic Solid TumorRecurrent Solid TumorAdvanced Solid Tumor+11 more Eli Lilly and Company 490
Large-scale testing (Phase 3)Looking for participantsNCT07087054What this trial is testingCarcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine RegimenWho this might be right forCarcinoid SyndromeCarcinoidCarcinoid Tumor+6 more Crinetics Pharmaceuticals Inc. 141
Testing effectiveness (Phase 2)Looking for participantsNCT05431270What this trial is testingDose Escalation/Expansion Study of Mavrostobart (PT199), an Anti-CD73 mAb, Administered Alone and in Combination With a PD-1 Inhibitor or Chemotherapy (the MORNINGSTAR Study)Who this might be right forNon Small Cell Lung CancerPancreatic Ductal Adenocarcinoma Phanes Therapeutics 40
Early research (Phase 1)Not Yet RecruitingNCT07807956What this trial is testingAssess Adverse Events, Change in Disease Activity and How Intravenous ABBV-253 Moves Through the Body in Adult Participants With Advanced Solid TumorsWho this might be right forAdvanced Solid TumorsNon-Small Cell Lung CancerColorectal Cancer+6 more AbbVie 130
Not applicableLooking for participantsNCT04622423What this trial is testingAdvanced Therapies for Liver MetastasesWho this might be right forPancreatic Ductal Adenocarcinoma (PDAC)Colorectal Cancer (CRC)Liver Metastasis+1 more IRCCS San Raffaele 625
Early research (Phase 1)Ended earlyNCT04042480What this trial is testingSGN-CD228A in Advanced Solid TumorsWho this might be right forCutaneous MelanomaPleural MesotheliomaHER2 Negative Breast Neoplasms+3 more Seagen Inc. 88
Testing effectiveness (Phase 2)Study completedNCT00093782What this trial is testingTemsirolimus in Treating Patients With Metastatic Neuroendocrine CarcinomaWho this might be right forMetastatic Gastrointestinal Carcinoid TumorPulmonary Carcinoid TumorRecurrent Gastrointestinal Carcinoid Tumor+1 more National Cancer Institute (NCI) 36
Not applicableLooking for participantsNCT01365169What this trial is testingAssociation Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"Who this might be right forMalignant Head and Neck NeoplasmMalignant NeoplasmMetastatic Malignant Neoplasm in the Neck+45 more M.D. Anderson Cancer Center 590
Not applicableAvailableNCT07262970What this trial is testingIntermediate-Size Cohort EAP for Ersodetug in Patients With Inadequately Controlled Hypoglycemia Related to a TumorWho this might be right forTumor-associated Hyperinsulinism (Tumor HI) Rezolute
Not applicableUnknownNCT05566093What this trial is testingEUS-FNI for Nonfunctional Pancreatic Neuroendocrine TumorsWho this might be right forNonfunctional Pancreatic Neuroendocrine TumorPancreatic Neuroendocrine TumorEndoscopic Ultrasound Guangxi Medical University 20
Not applicableLooking for participantsNCT05297734What this trial is testingComparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With CancerWho this might be right forEnd of LifeCancer Stanford University 2,996
Testing effectiveness (Phase 2)Active Not RecruitingNCT05922930What this trial is testingStudy of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells Delivered Intraperitoneally for the Management of Platinum Resistant Ovarian Cancer, Mesonephric-like Adenocarcinoma, and Pancreatic CancerWho this might be right forPancreatic CancerOvarian CancerAdenocarcinoma M.D. Anderson Cancer Center 51
Not applicableNot Yet RecruitingNCT07670871What this trial is testingExocrine-Endocrine Pancreatic Crosstalk: Precision Pathways to Reframe Diabetes PathophysiologyWho this might be right forType 2 Diabetes Mellitus (T2DM)Chronic PancreatitisPrediabetes+1 more Fondazione Policlinico Universitario Agostino Gemelli IRCCS 440
Testing effectiveness (Phase 2)Study completedNCT00781911What this trial is testingCixutumumab (IMC-A12) in Islet Cell CancerWho this might be right forCarcinomaNeuroendocrine Tumors Eli Lilly and Company 43